diagnost tool
somber analyst day suspect guid
like one-off maintain buy
quest miss wrote buy thesi challeng await
greater visibl unfortun analyst day guid declin
provid much visibl guid stock like dead money
print guid think guid mark worst-cas scenario
lack certainti suspect guid one-tim event mainli relat
accrual account stock yesterday trade
reduc adj ep estim stock yield net net
investor look inexpens industry-lead stock trade near decade-trough
ep multipl pay dividend yield think worthi look
must stick buy rate lower pt base
adj ep estim
bad news first good news maintain revenue compound-annual-growth-rate
target increas revenue target target
size increas health plan revenu opportun mainli net share
gain lh assum share revenue opportun time
remind tailwind remind investor tailwind remain
expand health plan access live anthem horizon georgia
 revenue growth/year invigor cost save
author look like good time buy thu think adj ep could look
bad news lower revenue guid much ep
cfo mainli due updat complex accrual assumpt
see plu impact relat ca fire coast snowstorm last week
lower four-year earn growth target compound-annual-growth-rate mid-to-high-
singl digit cite headwind reimburs
pama carryov test headwind hcvg vit wage
inflat clearli highlight challeng year ahead
accrual account issu one-tim event topic crystal clear
us sens manag took conserv tack guid
manag indic revenu accrual highli complex given larg number
assumpt make base rate payor denial payment histori payor
mix price chang also note health plan alway provid
compani updat membership list live shift ff cap
plan lead chang accrual
guid guid indic revenu earn
grow y/i expect modest growth market share gain lh thank
gain access off-set reimburs cut
opportun cite opportun reduc test denial
opportun acceler digit opportun
consolid immuno-assay provid opportun year
price close busi novemb
largest clinic lab us
focus routin gene-bas esoter test
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ object view
compani secur subject report discuss herein
import inform pleas see import disclosur begin page document
somber analyst day suspect
guid like one-off maintain buy
quest miss wrote buy thesi challeng await
greater visibl unfortun analyst day guid declin
provid much visibl guid stock like dead money
print guid think guid mark worst-cas
scenario lack certainti suspect guid one-tim event
mainli relat accrual account stock yesterday
trade reduc adj ep estim stock yield
net net investor look inexpens industry-lead stock trade
near decade-trough ep multipl pay dividend yield think
worthi look must stick buy rate lower
pt base adj ep estim
figur quest compris total us lab market
figur quest data show slight edg rival labcorp independ lab segment
buy unchang target price novemb
diagnost tool
model chang take estim
move line dgx target lower revenu estim
y/i y/i line dgx guid lower
adj ep estim y/i vs dgx guid
greater haircut revenu growth project
trim adj ep
estim y/i vs dgx long-term ep compound-annual-growth-rate
target model contempl futur contribut
expect contribut point growth long-term revenu compound-annual-growth-rate
bad news first good news
maintain revenu compound-annual-growth-rate target increas
revenu target target size increas health
plan revenu opportun mainli net share gain lh
assum share revenue opportun time also rais
dividend annual
remind tailwind
remind investor tailwind remain expand health plan access
live anthem horizon georgia revenue growth/year
invigor cost save earn
growth target exclud share buyback author look like good
time buy thu think adj ep could look like
lower revenue guid much ep
cfo mainli due updat complex accrual assumpt see
plu impact relat california fire east coast snowstorm last week
lower four-year earn growth target compound-annual-growth-rate mid-to-high-
singl digit cite headwind reimburs
pama carryov test headwind hcvg vit
wage inflat clearli highlight challeng year ahead
accrual account issu one-tim event
topic crystal clear us sens manag took
conserv tack guid manag indic revenu accrual
highli complex given larg number assumpt make base
rate payor denial payment histori payor mix price chang
also note health plan alway provid compani updat
membership list live shift ff cap plan lead
chang accrual
guid indic revenu earn grow y/i
expect modest growth market share gain lh thank
gain access off-set reimburs cut
cite opportun reduc test denial opportun
acceler digit opportun consolid six
immuno-assay provid one opportun five year
underestim bill denial key driver quest lower guid
given quarter quest report revenu account receiv subject
compani judgment estim bill denial collect revenu
accrual certainli complic process highli depend underli
buy unchang target price novemb
diagnost tool
bill collect payor price/payor mix estim quest also face challeng
track individu payment mani payor provid quest
outdat membership databas inform quest indic
major guid relat revenu account receiv
issu compani deviat standard methodolog deriv
estim quarter issu simpli stem quest
underestim true bill denial rate seen thu far quest consid
issu one-tim effect expect issu continu
break quest lower guid
lower revenu guidanc y/i
volum soft aforement increas reserv associ
revenu account receiv lower adj ep guidanc
y/i vs prior
expect deliv cash provid oper
quest lower guid larg due expect increas reserv associ
revenu account receiv due prior underestim bill denial
lesser driver guid volum soft driven
hurrican michael california wildfir recent east coast snowstorm linger
headwind prescript drug monitor hepat genotyp vitamin
test recal call lower-than-expect growth due polici
chang payor limit mostli unnecessari confirmatori test
lobbi payor chang polici revers one payor decis
hcv test see pressur due rapid uptak new mavyret drug
genotyp lower demand hepat genotyp hcvg
guid updat financi target
re-affirmed four-year revenu compound-annual-growth-rate target
contempl point higher revenu contribut prior
organ growth expect deliv four-year earn compound-annual-growth-rate
compar prior goal mid high singl digit growth note
dgx earn compound-annual-growth-rate relat overal earn growth ep
assum chang share count repurchas share sinc
author repurchas addit expect
priorit share repurchas believ execut
outstand repurchas author would mark upsid long-term
guid expect revenu earn grow despit face
peak reimburs pressur neg impact pama
health plan access expect tailwind
expand health plan access new live continu cost
effici growth depend pace transact
note number deal thought would close look like
event quickli win share new major health plan
expect modest growth believ market share gain lh live
help acceler revenu growth
put take pama
quest deriv total revenu
clinic lab fee schedul clf quest estim cut clf pama
expect cut rise
believ pama cut felt
cautious optimist may see inclus hospit outreach lab rate
buy unchang target price novemb
diagnost tool
figur expect feel peak hit pama pressur follow moder pressur beyond
weight median formula next data collect period
happen could provid relief quest well lh year
reimburs revenue/requisit revenu
dgx market research suggest hospit execut
familiar pama came surpris us feel good
pipelin like expand smaller less-effici lab feel pinch rate cut
realiz put sale prudent despit slower-than-
expect start pama consolid track deliv growth
 transact expect acceler acquisit
particularli lab feel sting reimburs cut
chanc pama fix place low odd somewher around chang
pama think chanc indic compani trade group
acla work congress improv pama outcom plan
worst hope best think chang like help off-set
magnitud rate cut year
oper busi assumpt pama current form
stay late septemb cite lack subject matter jurisdict us
district court judg dismiss american clinic laboratori associ acla
lawsuit implement new medicar price lab test pama
quest ceo steve rusckowski indic acla appeal district court
decis continu engag regard data collect method
new access live present annual revenu opportun
effect januari quest becom in-network lab provid
unitedhealthcar anthem horizon anthem georgia add access
million new live quest estim newli servic live repres
increment growth opportun annual lab revenu quest
estim own independ lab segment vs lh
believ may captur similar proport new revenu
buy unchang target price novemb
diagnost tool
opportun quest improv health plan access strengthen
market posit major state ca tx fl ny materi enhanc access
ga nj begun construct new flagship lab
figur believ captur increment revenu opportun new patient live
begun reach physician unit network use
lh in-network lab alreadi win new custom identifi
reach high-util account believ repres
revenu opportun fulli convert quest within account
identifi account consid quest loyalist like shift
major lab provid remain account mix provid use
along lh lab continu court quest initi
target short-term high-util account later pursu
addit medium-term account repres compani see
revenu opportun long-term account repres
rais growth outlook
quest expect contribut point growth revenu
compound-annual-growth-rate vs prior expect point despit compani
consid slow start pama consolid believ track deliv
north point growth believ pama consolid
start evidenc hospit execut indic
familiar pama accord expect pace heat
smaller lab grappl rise wage pressur reimburs cut pama
realiti economi scale matter look get busi
buy unchang target price novemb
diagnost tool
figur priorit share repurchas remain financi disciplin choos target
complet nine hospit outreach acquisit sinc remain
focus consolid segment lab market dialogu
sever hospit outreach lab hospit outreach lab
market compris institut gener
annual revenu addit smaller hospit outreach lab
gener annual revenu quest estim consolid
figur believ earliest stage consolid smaller ineffici lab deepli affect pama
buy unchang target price novemb
diagnost tool
make solid progress advanc consum digit project
continu execut strategi becom consumer-friendli
increasingli digit world continu add featur myquest mobil
applic user myquest allow patient schedul lab
visit view test result keep track famili member health inform
new mycircl featur mani quest patient servic center offer full
digit experi start digit echeck-in ipad quest indic
highest level unaid consum brand awar among lab provid
high level satisfact among patient use servic
increasingli focus popul health name enabl health plan
provid better assess popul close gap care focu
connect patient phone home retail store announc
earli februari complet acquisit mobil medic examin servic
medxm provid home-bas health risk assess relat servic
hold substanti valu roughli billion lab test data point
system expect time seek monet data greater way
believ digit present cost save opportun five year
believ drive patient pre-registr appoint
schedul convers paper erequisit physician
offic logist improv call center optim
figur dgx digit effort drive cost save make custom live easier
earli novemb launch questdirect on-line consum test servic
allow consum order one quest differ health
well lab test conveni home though questdirect
consum schedul one quest lab test complet one
health women health digest health heart health infecti diseas sti
buy unchang target price novemb
diagnost tool
other essenc featur help cut wait time patient servic
center help empow individu take control care
newest lab futur lab buildout plan progress schedul
quest break ground new lab clifton nj larger
marlborough lab futur current largest autom lab world
understand quest plan tear older teterboro nj lab
replac larger version state-of-the-art marlborough lab wherea
use exist build marlborough lab expect build teterboro
lab ground consolid three exist lab baltimor
philadelphia exist teterboro lab expect provid greater
capac capabl process specimens/night improv
product expect like achiev cost synergi consolid
real estat footprint quantifi target yet
look drive annual cost save move forward
quest deliv cost save sinc implement invigor
program exceed goal set go-forward goal
deliv annual cost save cost structur roughli
figur exceed prior goal drive cost save look drive annual cost save go forward
sourc cost save includ consolid system facil e-
enabl autom effort dgx order done electron
reduc million annual bad debt within five
year work optim patient bill process adjud
requisit test complet similar hotel guest provid credit
card incident charg upon check hotel anecdot dgx
time per patient minut would move needl
buy unchang target price novemb
diagnost tool
figur year significantli improv number effici metric
stock price compani discuss report
laboratori corpor america hold lh nyse hold
buy unchang target price novemb
diagnost tool
canaccord genuiti estim compani report
buy unchang target price novemb
diagnost tool
canaccord genuiti estim compani report
buy unchang target price novemb
diagnost tool
